# Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/vedolizumab-in-patients-with-concurrent-primary-sclerosing-cholangitis-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Britt Christensen,Dejan Micić,Peter G. Gibson,Andrés Yarur,Emanuelle Bellaguarda,Paul M. Corsello,John N. Gaetano,Jami Kinnucan,Vijaya L. Rao,S. Reddy,Siddharth Singh,Joel Pekow,David T. Rubin |
| Citations | 87 |
| DOI | 10.1111/apt.14525 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14525 |
| OpenAlex ID | https://openalex.org/W2794344940 |
| PMID | 29377235 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Dejan Micić](https://scholariq.org/researchers/dejan-micic/)
- [Jami Kinnucan](https://scholariq.org/researchers/jami-kinnucan/)

## Paper journal

- [Alimentary Pharmacology & Therapeutics](https://scholariq.org/journals/alimentary-pharmacology-and-therapeutics/)

## Paper primary topic

- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

## Paper topics

- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Pediatric Hepatobiliary Diseases and Treatments](https://scholariq.org/topics/pediatric-hepatobiliary-diseases-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.